Pavlovian Conditioned Approach, conditioned reinforcement, number of active nose-poke hole entries during the test
Tags: Behavior · Pavlovian conditioned approach · Conditioned reinforcement
Project: p50_paul_meyer_2014
1 locus · 1 gene with independent associations · 1 total associated gene
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | chr3 | 44152620 | 45549784 | 1 | 1 | 4.21e-09 | 2.42e-01 | 1.96e-09 | Ly75 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1.35 |
Adipose | alternative TSS | 0 | 0 | 1.45 |
Adipose | gene expression | 0 | 0 | 1.4 |
Adipose | isoform ratio | 0 | 0 | 1.35 |
Adipose | intron excision ratio | 0 | 0 | 1.2 |
Adipose | mRNA stability | 0 | 0 | 1.41 |
BLA | alternative polyA | 0 | 0 | 1.4 |
BLA | alternative TSS | 0 | 0 | 1.42 |
BLA | gene expression | 0 | 0 | 1.43 |
BLA | isoform ratio | 0 | 0 | 1.38 |
BLA | intron excision ratio | 0 | 0 | 1.39 |
BLA | mRNA stability | 0 | 0 | 1.4 |
Brain | alternative polyA | 0 | 0 | 1.38 |
Brain | alternative TSS | 0 | 0 | 1.41 |
Brain | gene expression | 0 | 0 | 1.42 |
Brain | isoform ratio | 0 | 0 | 1.42 |
Brain | intron excision ratio | 0 | 0 | 1.36 |
Brain | mRNA stability | 0 | 0 | 1.43 |
Eye | alternative polyA | 0 | 0 | 1.02 |
Eye | alternative TSS | 0 | 0 | 1.81 |
Eye | gene expression | 0 | 0 | 1.52 |
Eye | isoform ratio | 0 | 0 | 1.4 |
Eye | intron excision ratio | 0 | 0 | 1.63 |
Eye | mRNA stability | 0 | 0 | 1.5 |
IL | alternative polyA | 0 | 0 | 1.38 |
IL | alternative TSS | 0 | 0 | 1.32 |
IL | gene expression | 0 | 0 | 1.38 |
IL | isoform ratio | 0 | 0 | 1.34 |
IL | intron excision ratio | 0 | 0 | 1.19 |
IL | mRNA stability | 0 | 0 | 1.47 |
LHb | alternative polyA | 0 | 0 | 1.37 |
LHb | alternative TSS | 0 | 0 | 1.26 |
LHb | gene expression | 1 | 0 | 1.37 |
LHb | isoform ratio | 0 | 0 | 1.27 |
LHb | intron excision ratio | 0 | 0 | 1.23 |
LHb | mRNA stability | 0 | 0 | 1.4 |
Liver | alternative polyA | 0 | 0 | 1.32 |
Liver | alternative TSS | 0 | 0 | 1.38 |
Liver | gene expression | 0 | 0 | 1.41 |
Liver | isoform ratio | 0 | 0 | 1.34 |
Liver | intron excision ratio | 0 | 0 | 1.3 |
Liver | mRNA stability | 0 | 0 | 1.39 |
NAcc | alternative polyA | 0 | 0 | 1.36 |
NAcc | alternative TSS | 0 | 0 | 1.43 |
NAcc | gene expression | 0 | 0 | 1.45 |
NAcc | isoform ratio | 0 | 0 | 1.37 |
NAcc | intron excision ratio | 0 | 0 | 1.32 |
NAcc | mRNA stability | 0 | 0 | 1.45 |
OFC | alternative polyA | 0 | 0 | 1.29 |
OFC | alternative TSS | 0 | 0 | 1.32 |
OFC | gene expression | 0 | 0 | 1.4 |
OFC | isoform ratio | 0 | 0 | 1.3 |
OFC | intron excision ratio | 0 | 0 | 1.17 |
OFC | mRNA stability | 0 | 0 | 1.46 |
PL | alternative polyA | 0 | 0 | 1.41 |
PL | alternative TSS | 0 | 0 | 1.41 |
PL | gene expression | 0 | 0 | 1.44 |
PL | isoform ratio | 0 | 0 | 1.38 |
PL | intron excision ratio | 0 | 0 | 1.38 |
PL | mRNA stability | 0 | 0 | 1.48 |
pVTA | alternative polyA | 0 | 0 | 1.37 |
pVTA | alternative TSS | 0 | 0 | 1.42 |
pVTA | gene expression | 0 | 0 | 1.45 |
pVTA | isoform ratio | 0 | 0 | 1.35 |
pVTA | intron excision ratio | 0 | 0 | 1.39 |
pVTA | mRNA stability | 0 | 0 | 1.46 |
RMTg | alternative polyA | 0 | 0 | 1.13 |
RMTg | alternative TSS | 0 | 0 | 1.28 |
RMTg | gene expression | 0 | 0 | 1.39 |
RMTg | isoform ratio | 0 | 0 | 1.26 |
RMTg | intron excision ratio | 0 | 0 | 1.33 |
RMTg | mRNA stability | 0 | 0 | 1.49 |